×

 

 

Immuno-Oncology Summit Europe 2023

NOW AVAILABLE ON-DEMAND

Missed Immuno-Oncology Summit Europe This Year?

Access Digital Platform

Missed this year's event? Access content from across all of this year's programs On-Demand. At your convenience, access archived presentations for On-Demand learning, from anywhere, at any time.


Conference Programs Covering the Latest Immuno-Oncology Developments

About the Immuno-Oncology Summit Europe

CHI’s 7th Annual Immuno-Oncology Summit Europe returns to London’s Canary Wharf for three packed days of science and technology discussions on the recent advances in the development of promising immuno-oncology therapies.

The Summit, scheduled for 20-22 June 2023, comprises 4 conference programs, from strategies on Modulating the Tumour Microenvironment; to various treatment modalities including Next-Generation Cell-Based Immunotherapies; Bispecific and Multi-Specific Antibody Therapeutics, and Gamma Delta Immunotherapy.

Highlights include a Plenary Keynote Session featuring 4 distinguished Keynote Speakers; engaging Breakout Discussions that bring peers together to chat about current trends and latest developments on the most pressing or contentious topics; a balanced faculty of industry and academia speakers; and an Exhibit Hall showcasing the technology leaders in the IO space.

Join us at the Immuno-Oncology Summit Europe 2023 to meet peers, exchange ideas, and find collaborators to accelerate your next IO program.

Plenary Keynote Speakers

Zhen Su, MD, MBA

Zhen Su, MD, MBA
CEO, Marengo Therapeutics

Andrew Sewell, PhD

Andrew Sewell, PhD
Distinguished Research Professor and Wellcome Trust Senior Investigator, Division of Infection and Immunity, Cardiff University School of Medicine

Anne Rios, PhD

Anne Rios, PhD
Principal Investigator, Princess Maxima Center Pediatric Oncology

Christian Klein, PhD

Christian Klein, PhD
Head, Oncology Programs and Department Head, Cancer Immunotherapy Discovery, Roche Innovation Center Zurich